Edwards Lifesciences Corporation Common Stock vs ProShares UltraShort Bloomberg Natural Gas ETF — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $84.25 (market cap $49.44B), while ProShares UltraShort Bloomberg Natural Gas ETF trades at $25.74 (market cap $115.44M). The key difference: Edwards Lifesciences Corporation Common Stock is far larger — about 428.3× ProShares UltraShort Bloomberg Natural Gas ETF's market cap, and Edwards Lifesciences Corporation Common Stock is trading nearer its 52-week high, ProShares UltraShort Bloomberg Natural Gas ETF nearer its low. Which is the better fit depends on your goals.
| EW | KOLD | |
|---|---|---|
Market Cap | $49.44B | $115.44M |
Volume | 3,508,027 | 6,626,046 |
Sector | Health | Leveraged / Inverse |
52-Week High | $95.18 | $49.39 |
52-Week Low | $72.65 | $13.58 |
Enterprise Value | $45.90B | — |
Typical Hold Time | — | 10 Days |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
KOLD is trading at $24.84, down 5.8% over the past 24 hours amid bearish technical signals. The stock faces strong selling pressure with moving averages indicating a bearish trend and oscillators in neutral territory. Recent news highlights natural gas market volatility driven by record production levels and geopolitical tensions in the Middle East affecting energy commodities.
The outlook remains challenging with technical indicators pointing to continued downward pressure. Investment opportunities may emerge if the stock finds support near current levels, but risks include ongoing natural gas price volatility and geopolitical uncertainties. The bearish technical setup suggests cautious positioning is warranted until clearer fundamental catalysts emerge.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →KOLD is an inverse leveraged ETF that seeks to provide two times (2x) the inverse daily performance of the Bloomberg Natural Gas Subindex. It is designed for investors looking to profit from falling natural gas prices.
Read more on KOLD →